MedTrace Logo

Cathelicidin LL-37 Levels in the GCF and the Saliva of Smokers and Non-smokers With Stage III,IV Periodontitis

NCT04861493 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2021-04-27

No results posted yet for this study

Summary

Periodontitis is considered an inflammatory disease that results in the disruption of oral hemeostasis and is associated with the presence of dental plaque influenced by genetic and environmental factors. It is well-establised that smokers have an increased severity of periodontal disease,a higher prevalance of tooth loss and total edentulism.

Conditions

  • Smoking Reduction

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Ghallab · main supervisor

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-23
Primary Completion
2021-02-23
Completion
2021-04-15

Countries

  • Egypt

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04861493 on ClinicalTrials.gov